Johnson & Johnson reports clinical trial results for robotic surgery system
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
May 5, 2026 7:00 AM EDTStudy results represent a critical milestone for the investigational OTTAVA Robotic Surgical System
Data demonstrates feasibility of novel system architecture with tableintegrated robotic arms in spaceconstrained ORs
Abstract presented at the 2026 American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting Presidential Grand Round Sessions in San Antonio, Texas
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Today, Johnson & Johnson announced results from the first clinical study of the investigational OTTAVA Robotic Surgical System a prospective, multicenter clinical study evaluating the safety and performance of the... More
